A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL.
The file type is application/pdf.
Review 1: "Circulating SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity"
[peer_review]
2022
unpublished
Preserved Fulltext
The preprint entitled, "Circulating SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity," underlines the significance of developing new vaccines or reformulating current vaccines capable of cross-neutralization of emerging variants of SARS-CoV-2. The results of this study provide adequate evidence that BNT162b2 and mRNA-1273 vaccines are only protective of a few circulating SARS-CoV-2 variants through humoral immunity.
doi:10.1162/2e3983f5.a8b9c3be
fatcat:rlxlqqiz7nhm5as7einq5u45am